Doctors treating legendary thespian Dilip Kumar, who is undergoing treatment for kidney-related problems, are happy with the progress in his health, a senior official from the Lilavati Hospital here said on Tuesday.
"He is improving. His creatinine levels have come down further and doctors are happy with the progress in his health," Ajay Kumar Pande, Vice President, Lilavati Hospital, told IANS.
The 94-year-old is currently in the ICU of the hospital.
Asked about when is he likely to be discharged from the facility, Pande said: "It is not yet decided. But it may be discussed tomorrow."
The thespian was admitted to the hospital on August 2 due to dehydration and urinary tract infection. High potassium and creatinine levels had raised concerns that he may have to be put on dialysis, but doctors decided against it after he started responding well to treatment.
--IANS
rb/vt
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app